Russia's Sputnik V Coronavirus Vaccine Shown To Be 91.6 Percent Effective Following Interim Trials
The interim trial results of Sputnik V, the coronavirus vaccine developed by Russia, are in, and results are showing 91.6 percent effectiveness in preventing symptomatic cases, as reported by CNN. There were no severe adverse events that appeared to be associated with the vaccine and the only side effects reported being mild, consisting of flu-like symptoms, pain at the injection site and low energy. Following the phase three trial of the vaccine, interim data suggests that two doses of Sputni...
Marcos Brindicci Getty Alexander Edwards Reading School Of Pharmacy Russian Direct Investment Fund University Of Reading Biomedical Technology
Source: inquisitr.com